Ankara — Türkiye has increased the euro exchange rate used to calculate pharmaceutical prices, a move expected to affect medicine prices nationwide starting April 1.
The change follows a presidential decree published in the Official Gazette that amended the regulation on the pricing of medicinal products for human use. Under the new regulation, the fixed euro rate used in pharmaceutical pricing has been raised by about 17 percent.
According to the decision, the euro value used in the drug pricing system will rise from 21.6721 Turkish lira to 25.3346 lira. This reference exchange rate is a key component of Türkiye’s pharmaceutical pricing framework and determines how the retail prices of many medicines are calculated.
Implementation Date
The new exchange rate will take effect on April 1, meaning pharmaceutical companies and pharmacies will adjust prices based on the updated euro value from that date onward.
Updated Price Thresholds
Along with the increase in the euro rate, authorities also revised the price threshold values used in the pricing formula:
- 87.34 lira for price-protected medicines
- 45.64 lira for other pharmaceutical products
Impact on the Sector
Industry experts say the adjustment reflects rising production, import, and logistics costs faced by pharmaceutical companies. The change is expected to help manufacturers and suppliers cope with currency fluctuations, although it could also lead to higher medicine prices for consumers over time.
The euro reference rate is periodically updated by the government as part of Türkiye’s drug pricing system, which links medicine prices to a fixed exchange rate rather than the daily market value of the euro.
If you want, I can also rewrite it in a more professional “agency-style” news format (Reuters/Bloomberg style), which is often required for publications.
Source: Patronlar Dünyası/ Prepared by: İlayda Gök